MRTX1133 MECHANISM OF ACTION - AN OVERVIEW

The identification of KRASG12C inhibitors has reignited interest in focusing on RAS proteins. This operate describes the invention with the KRASG12D-certain inhibitor MRTX1133 and demonstrates the feasibility of potently and selectively concentrating on this oncogenic variant.A different opportunity benefit of combining KRAS inhibitors and checkpoi